These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9196521)

  • 21. Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension.
    Preston IR; Klinger JR; Landzberg MJ; Houtchens J; Nelson D; Hill NS
    Chest; 2001 Sep; 120(3):866-72. PubMed ID: 11555522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhaled nitric oxide for the adult respiratory distress syndrome.
    Rossaint R; Falke KJ; López F; Slama K; Pison U; Zapol WM
    N Engl J Med; 1993 Feb; 328(6):399-405. PubMed ID: 8357359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in the acute pulmonary vascular effects of oxygen with nitric oxide and diltiazem: implications for the long-term treatment of pulmonary arterial hypertension.
    Day RW
    Congenit Heart Dis; 2013; 8(1):71-7. PubMed ID: 22891699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.
    Sitbon O; Humbert M; Jaïs X; Ioos V; Hamid AM; Provencher S; Garcia G; Parent F; Hervé P; Simonneau G
    Circulation; 2005 Jun; 111(23):3105-11. PubMed ID: 15939821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pulmonary arterial hypertension treated with prostacyclin or calcium blockers].
    Andreassen AK; Geiran O; Madsen S; Hognestad A; Simonsen S
    Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3393-6. PubMed ID: 14713978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension.
    Prielipp RC; McLean R; Rosenthal MH; Pearl RG
    Crit Care Med; 1991 Jan; 19(1):60-7. PubMed ID: 1986891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential therapy with calcium antagonists in pulmonary hypertension secondary to COPD. Hemodynamic effects of nifedipine, diltiazem, and verapamil.
    Gassner A; Sommer G; Fridrich L; Magometschnigg D; Priol A
    Chest; 1990 Oct; 98(4):829-34. PubMed ID: 2209138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome.
    Walmrath D; Schneider T; Schermuly R; Olschewski H; Grimminger F; Seeger W
    Am J Respir Crit Care Med; 1996 Mar; 153(3):991-6. PubMed ID: 8630585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension.
    Inbar S; Schrader BJ; Kaufmann E; Vestal RE; Rich S
    J Am Coll Cardiol; 1993 Feb; 21(2):413-8. PubMed ID: 8426006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhalative strategies for improvement of pulmonary hemodynamics and gas exchange in sepsis and severe pulmonary hypertension].
    Grimminger F; Rose F; Ghofrani HA; Schermuly RT; Weissmann N; Olschewski H; Walmrath D; Seeger W
    Z Kardiol; 2000 Jun; 89(6):477-84. PubMed ID: 10929431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute vasoreactivity testing with nicardipine in patients with pulmonary arterial hypertension.
    Saito Y; Nakamura K; Miyaji K; Akagi S; Mizoguchi H; Ogawa A; Fuke S; Fujio H; Kiyooka T; Nagase S; Kohno K; Morita H; Kusano KF; Matsubara H; Ohe T; Ito H
    J Pharmacol Sci; 2012; 120(3):206-12. PubMed ID: 23117888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators.
    Houde C; Bohn DJ; Freedom RM; Rabinovitch M
    Br Heart J; 1993 Nov; 70(5):461-8. PubMed ID: 8260279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
    Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment.
    Petkov V; Ziesche R; Mosgoeller W; Schenk P; Vonbank K; Stiebellehner L; Raderer M; Brunner C; Kneussl M; Block LH
    Thorax; 2001 Sep; 56(9):734-6. PubMed ID: 11514696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension.
    Adnot S; Kouyoumdjian C; Defouilloy C; Andrivet P; Sediame S; Herigault R; Fratacci MD
    Am Rev Respir Dis; 1993 Aug; 148(2):310-6. PubMed ID: 8342892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension.
    Voswinckel R; Reichenberger F; Enke B; Kreckel A; Krick S; Gall H; Schermuly RT; Grimminger F; Rubin LJ; Olschewski H; Seeger W; Ghofrani HA
    Pulm Pharmacol Ther; 2008 Oct; 21(5):824-32. PubMed ID: 18657627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined inhaled nitric oxide and inhaled prostacyclin during experimental chronic pulmonary hypertension.
    Hill LL; Pearl RG
    J Appl Physiol (1985); 1999 Apr; 86(4):1160-4. PubMed ID: 10194197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in the treatment of pediatric pulmonary artery hypertension.
    Barst RJ
    Pediatr Clin North Am; 1999 Apr; 46(2):331-45. PubMed ID: 10218078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Echocardiographic predictors of an adverse response to a nifedipine trial in primary pulmonary hypertension: diminished left ventricular size and leftward ventricular septal bowing.
    Ricciardi MJ; Bossone E; Bach DS; Armstrong WF; Rubenfire M
    Chest; 1999 Nov; 116(5):1218-23. PubMed ID: 10559078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.